Sanofi Pasteur may not charge the U.S. government more than other G7 countries for its coronavirus vaccine candidate, according to a redacted contract posted on HHS’ website.
NON-SUBSCRIBER OPTIONS
FREE TRIAL | NEWSSTAND
Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.
Log in to access this content.
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.
© 2002-2020. Inside Washington Publishers | Contact Us